Apart from the mutations leading to GLUT1DS and PDCD, other mutations result in epileptic encephalopathies that respond well to KD treatment, such as KCNQ2, SCN1A, SCN2A, or STXBP1 [43,44]. Here, SLC2A1 is linked to Epileptic encephalopathy.